Literature DB >> 25272495

[Synthesis and protective effect of ligustrazine intermediates against CoCl2-induced neurotoxicity in differentiated PC12 cell].

Guo-Liang Li, Peng-Long Wang, Xin Xu, Jin-Xuan Lin, Fu-Hao Chu, Ji-Xiang Song, Shen Zhou, Mi-Na Wang, Yu-Zhong Zhang, Hai-Min Lei.   

Abstract

Ligustrazine, one of the major effective components of the Chinese traditional medicinal herb Ligusticum Chuanxiong Hort, has been reported plenty of biological activities, such as protect cardiovascular and cerebrovascular, neuroprotection and anti-tumor, et al. Because of its remarkable effects, studies on structural modification of ligustrazine have attracted much attention. Ligustrazine synthetic derivatives reported in recent decades are mainly derived from four primary intermediates (TMP-COOH, TMP-OH, TMP-NH2, HO-TMP-OH). To explore the neuroprotection activitiy of ligustrazine intermediates, six ligustrazine intermediates (2, 5, 8, 11, 12, 13) were synthesized and their protective effects against CoCl2-induced neurotoxicity in differentiated PC12 cells were studied. The target compounds were prepared via different chemical methods, including oxidation, substitution, esterification and amidation without changing the structure nucleus of ligustrazine. Compared with TMP (EC50 = 56.03 micromol x L(-1)), four compounds (2, 5, 12 and 13) exhibited higher activity (EC50 < 50 micromol x L(-1)) respectively, of which, compound 2 displayed the highest protective effect against the damaged PC12 cells (EC50 = 32.86 micromol x L(-1)), but target compounds 8 and 11 appeared lower activity (EC50 > 70 micromol x L(-1)). By structure-activity relationships analysis, the introduction of carboxyl, amino to the side chain of ligustrazine and appropriately increase the proportion of ligustrazine may contribute to enhance its neuroprotective activity, which provides a reference for the design, synthesis and activity screening of relevant series of ligustrazine derivatives in the future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25272495

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  A Novel Ligustrazine Derivative T-VA Prevents Neurotoxicity in Differentiated PC12 Cells and Protects the Brain against Ischemia Injury in MCAO Rats.

Authors:  Guoling Li; Guoliang Li; Yufei Tian; Yuzhong Zhang; Ying Hong; Yingzhi Hao; Chunxiao Chen; Penglong Wang; Haimin Lei
Journal:  Int J Mol Sci       Date:  2015-09-09       Impact factor: 5.923

2.  Synthesis and protective effect of new ligustrazine-vanillic acid derivatives against CoCl2-induced neurotoxicity in differentiated PC12 cells.

Authors:  Bing Xu; Xin Xu; Chenze Zhang; Yuzhong Zhang; GaoRong Wu; Mengmeng Yan; Menglu Jia; Tianxin Xie; Xiaohui Jia; Penglong Wang; Haimin Lei
Journal:  Chem Cent J       Date:  2017-02-28       Impact factor: 4.215

3.  Synthesis and Discovery of Ligustrazine-Heterocycle Derivatives as Antitumor Agents.

Authors:  Shitang Ma; Ning Zhang; Jiafu Hou; Shijuan Liu; Jiawen Wang; Baowei Lu; Fucheng Zhu; Peipei Wei; Ge Hong; Tianjun Liu
Journal:  Front Chem       Date:  2022-07-25       Impact factor: 5.545

4.  Novel Neuroprotective Lead Compound Ligustrazine Derivative Mass Spectrometry Fragmentation Rule and Metabolites in Rats by LC/LTQ-Orbitrap MS.

Authors:  Xinyu Zhang; Rui Zhao; Meng Chen; Tao Ma; Gaorong Wu; Nannan Xue; Guoliang Li; Hui Wang; Kang Fang; Wenxi Zhang; Penglong Wang; Haimin Lei
Journal:  Molecules       Date:  2018-05-11       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.